Eltrombopag Combining Rituximab Versus Eltrombopag in the Management of Primary Immune Thrombocytopenia (ITP) in Adults

Categoría Estudio primario
Registro de estudiosclinicaltrials.gov
Año 2020
Cargando información sobre las referencias
This multicenter randomized, open-label study aimed to compare the efficacy and safety of eltrombopag combining rituximab with eltrombopag in China adult ITP patients .This study was be conducted in adult ITP patients who had not responded to or had relapsed after previous treatment of ITP, including first line therapy and /or splenectomy.
Epistemonikos ID: 4bf4e7d6d6ffbde4bafbeb08edbe3138086bcfee
First added on: May 07, 2024